The engineered peptides are said to kill resistant bacteria while sparing human cells. Details on the study and its source are thin.
Recap by typeshit. Post by Facebook on Facebook.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Sehar Shahid explains how she runs a weight loss clinic out of her internet pharmacy, 24-hour Pharmacy. Few other details are given.
Australia's weight loss market could change as an oral GLP-1 pill moves closer to regulatory approval, 7NEWS Adelaide reports. Few details given so far.
Loading…